Strongyloides stercoralis, Human T-cell Lymphotropic Virus Type-1 and Cytomegalovirus Coinfection in an Allogeneic Hematopoietic Stem-Cell Transplant Recipient
Open Access
- 23 June 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 6 (7) , e573
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cytomegalovirus-induced immunopathology and its clinical consequencesHerpesviridae, 2011
- Strongyloidiasis-Related Deaths in the United States, 1991–2006The American Journal of Tropical Medicine and Hygiene, 2010
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveTransplantation and Cellular Therapy, 2009
- Effect of treatment of Strongyloides infection on HTLV‐1 expression in a patient with adult T‐cell leukemiaAmerican Journal of Hematology, 2007
- Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4+25+ HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralisOncogene, 2002
- Strongyloidiasis Refractory to Treatment With IvermectinThe American Journal of the Medical Sciences, 1996
- Immunoepidemiologic Studies of Strongyloides stercoralis and Human T Lymphotropic Virus Type I Infections in JamaicaThe Journal of Infectious Diseases, 1994
- Monoclonal integration of HTLV‐I proviral DNA in patients with strongyloidiasisInternational Journal of Cancer, 1987
- STRONGYLOIDES STERCORALIS AS CANDIDATE CO-FACTOR FOR HTLV-I-INDUCED LEUKAEMOGENESISThe Lancet, 1987
- HIGH INCIDENCE OF HTLV ANTIBODY IN CARRIERS OF STRONGYLOIDES STERCORALISThe Lancet, 1984